E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs

How to cite

Sacarny, Adam; Jacobson, Mireille; Avilova, Tatyana. 2024. "E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs." AEA RCT Registry. AEARCTR-0013549. https://doi.org/10.1257/rct.13549-1.5

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Adam Sacarny* , Mireille Jacobson , Tatyana Avilova

* Primary investigator

Registry ID
AEARCTR-0013549
DOI
https://doi.org/10.1257/rct.13549-1.5
First registered
Last updated
Status
Completed
Trial dates
2024-07-17 – 2025-09-24
Countries
United States of America (Minnesota)
JEL codes
I18, H75
Registry record
http://www.socialscienceregistry.org/trials/13549

Abstract

Drug overdose deaths have skyrocketed in recent years, and many overdoses continue to involve prescribed medications like opioids and stimulants. At the same time, state prescription drug monitoring programs (PDMPs), which help clinicians prescribe these medications safely, remain underused. In Minnesota, 32% of opioid prescriptions are written by clinicians who do not use the PDMP. In many states, including Minnesota, policymakers have limited tools to raise PDMP use even though it is often required under state law. To address this policy dilemma, we will test e-mails designed to facilitate PDMP use and evaluate their effects on PDMP use and controlled substance prescribing. Our work will include a projected 7,126 physician and physician assistant prescribers of opioids and other controlled substances who lack active PDMP accounts, never query the PDMP, or query the PDMP infrequently relative to their prescribing volume. To generate evidence on clinician motivation for responding to encouragement, we will randomly vary messaging to focus on legal requirements to use the PDMP vs. clinical benefits of the PDMP.

Intervention

Prescribers will be assigned at random to one of three arms:
1. PDMP Legal Mandate E-mails: Clinicians are sent e-mails highlighting the state’s legal requirements to use the PDMP.
2. PDMP Clinical Benefit Emails: Clinicians are sent emails highlighting the clinical benefits of having access to the PDMP and checking the PDMP before prescribing opioids.
3. Control: These clinicians are not sent any emails through this trial.

Each arm will receive one initial email and one follow-up email one month later.

Experimental design

This study will enroll Minnesota physicians and physician assistants who are not following the state’s requirements to maintain a PDMP account or search the PDMP. Specifically, clinicians who prescribe controlled substances but lack an account or have allowed their account to become inactive, as well as clinicians who prescribe opioids but do not search the PDMP or search infrequently relative to their prescribing, will be enrolled. Clinicians will be randomized at 1:1:1 ratio to two treatment arms and a control group.

Design details

Randomization method
Randomization with optimal stratification to maximize statistical power on primary prescribing endpoint
Randomization unit
Clinicians
Clusters
7,126 clinicians
Observations
7,126 clinicians
Arms
2,375 clinicians per arm
Primary outcomes
1) PDMP engagement and 2) potentially guideline-discordant opioid prescribing
Secondary outcomes
Secondary outcomes include search query volume, creation of delegate users, characteristics of average patient searched by clinicians, e-mail engagement (open, click-through, and bounce), and volume measures of prescribing (e.g. days supplied of controlled substances, days supplied of opioids, and total opioid morphine milligram equivalents). The full set of secondary outcomes will be specified in the pre-analysis plan.
Sponsors
Name: Abdul Latif Jameel Poverty Action Lab (J-PAL) Location: Cambridge, MA Url: https://www.povertyactionlab.org

Cited by

No citation data available for this registration yet.

Keywords